Clinical Trial

Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to assess several components of cognition in patients recently diagnosed with advanced epithelial ovarian cancer and who will be undergoing neoadjuvant chemotherapy for treatment of the cancer. 18 participants will be enrolled and can expect to be on study for approximately 10 months.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2025-08-08; most recent amendment 2026-04-29.
Status change: Not Yet Recruiting → Recruiting 2026-01-27
Trial Details
NCT Number NCT07125209
Lead Sponsor University of Wisconsin, Madison
Conditions Ovarian Cancer, Cognitive Change
Enrollment 18 participants
Start Date 2026-04-28
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-05